| US renal data system 2016 annual data report: epidemiology of kidney disease in the United States R Saran, B Robinson, KC Abbott, LYC Agodoa, P Albertus, J Ayanian, ... American journal of kidney diseases 69 (3), A7-A8, 2017 | 5570 | 2017 |
| Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation JV Freeman, RP Zhu, DK Owens, AM Garber, DW Hutton, AS Go, ... Annals of internal medicine 154 (1), 1-11, 2011 | 545 | 2011 |
| Cost-effectiveness of aflibercept, bevacizumab, and ranibizumab for diabetic macular edema treatment: analysis from the diabetic retinopathy clinical research network … EL Ross, DW Hutton, JD Stein, NM Bressler, LM Jampol, AR Glassman, ... JAMA ophthalmology 134 (8), 888-896, 2016 | 235 | 2016 |
| Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B DW Hutton, D Tan, SK So, ML Brandeau Annals of internal medicine 147 (7), 460-469, 2007 | 214 | 2007 |
| Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009 N Khazeni, DW Hutton, AM Garber, N Hupert, DK Owens Annals of Internal Medicine 151 (12), 829-839, 2009 | 143 | 2009 |
| Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma JD Stein, DD Kim, WW Peck, SM Giannetti, DW Hutton Archives of ophthalmology 130 (4), 497-505, 2012 | 126 | 2012 |
| Projected increase in obesity and non‐alcoholic‐steatohepatitis–related liver transplantation waitlist additions in the United States ND Parikh, WJ Marrero, J Wang, J Steuer, EB Tapper, M Konerman, ... Hepatology 70 (2), 487-495, 2019 | 121 | 2019 |
| Cost-effectiveness of hepatocellular carcinoma surveillance: an assessment of benefits and harms ND Parikh, AG Singal, DW Hutton, EB Tapper Official journal of the American College of Gastroenterology| ACG 115 (10 …, 2020 | 118 | 2020 |
| Switching to less expensive blindness drug could save medicare part B $18 billion over a ten-year period D Hutton, PA Newman-Casey, M Tavag, D Zacks, J Stein Health affairs 33 (6), 931-939, 2014 | 103 | 2014 |
| Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United States PM Stranges, DW Hutton, CD Collins Value in health 16 (2), 297-304, 2013 | 103 | 2013 |
| Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration JD Stein, PA Newman-Casey, T Mrinalini, PP Lee, DW Hutton Ophthalmology 121 (4), 936-945, 2014 | 97 | 2014 |
| Cost‐effectiveness of nationwide hepatitis B catch‐up vaccination among children and adolescents in China DW Hutton, SK So, ML Brandeau Hepatology 51 (2), 405-414, 2010 | 93 | 2010 |
| Cost effectiveness of regorafenib as second‐line therapy for patients with advanced hepatocellular carcinoma ND Parikh, AG Singal, DW Hutton Cancer 123 (19), 3725-3731, 2017 | 90 | 2017 |
| Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016–30 D Tordrup, Y Hutin, K Stenberg, JA Lauer, DW Hutton, M Toy, N Scott, ... The Lancet Global Health 7 (9), e1180-e1188, 2019 | 89 | 2019 |
| Cost-effectiveness of intravitreous ranibizumab compared with panretinal photocoagulation for proliferative diabetic retinopathy: secondary analysis from a diabetic retinopathy … DW Hutton, JD Stein, NM Bressler, LM Jampol, D Browning, ... JAMA ophthalmology 135 (6), 576-584, 2017 | 84 | 2017 |
| Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema JD Stein, PA Newman-Casey, DD Kim, KH Nwanyanwu, MW Johnson, ... Ophthalmology 120 (9), 1835-1842, 2013 | 75 | 2013 |
| Predictors of deceased donor kidney discard in the United States WJ Marrero, AS Naik, JJ Friedewald, Y Xu, DW Hutton, MS Lavieri, ... Transplantation 101 (7), 1690-1697, 2017 | 74 | 2017 |
| Cost-effectiveness analysis of alternative naloxone distribution strategies: first responder and lay distribution in the United States T Townsend, F Blostein, T Doan, S Madson-Olson, P Galecki, DW Hutton International journal of drug policy 75, 102536, 2020 | 71 | 2020 |
| Cost-effectiveness of access expansion to treatment of hepatitis C virus infection through primary care providers T Rattay, IP Dumont, HS Heinzow, DW Hutton Gastroenterology 153 (6), 1531-1543. e2, 2017 | 69 | 2017 |
| Cost-effectiveness model for hepatitis C screening and treatment: implications for Egypt and other countries with high prevalence DD Kim, DW Hutton, AA Raouf, M Salama, A Hablas, IA Seifeldin, ... Global public health 10 (3), 296-317, 2015 | 64 | 2015 |
Mariel LavieriUniversity of Michiganכתובת אימייל מאומתת בדומיין umich.edu